About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Cd47tm1Fpl
targeted mutation 1, Frederik P Lindberg
MGI:1861955
Summary 7 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Cd47tm1Fpl/Cd47tm1Fpl B6.129S7-Cd47tm1Fpl MGI:4430388
hm2
Cd47tm1Fpl/Cd47tm1Fpl C.129S7-Cd47tm1Fpl MGI:4939896
hm3
Cd47tm1Fpl/Cd47tm1Fpl involves: 129S7/SvEvBrd MGI:2180896
hm4
Cd47tm1Fpl/Cd47tm1Fpl involves: 129S7/SvEvBrd * C57BL/6 MGI:4939899
hm5
Cd47tm1Fpl/Cd47tm1Fpl NOD.129S7-Cd47tm1Fpl MGI:4939898
ht6
Cd47tm1Fpl/Cd47+ B6.129S7-Cd47tm1Fpl MGI:2180897
cx7
Rag2tm1Fwa/Rag2tm1Fwa
Cd47tm1Fpl/Cd47tm1Fpl
Il2rgtm1Cgn/Y
involves: 129P2/OlaHsd * 129S/SvEv * 129S7/SvEvBrd * C57BL/6 MGI:5538575


Genotype
MGI:4430388
hm1
Allelic
Composition
Cd47tm1Fpl/Cd47tm1Fpl
Genetic
Background
B6.129S7-Cd47tm1Fpl
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd47tm1Fpl mutation (4 available); any Cd47 mutation (45 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• following i.p. injection of 5 x 104 virulent E.coli (018:K1:H7), all 8-week-old homozygotes die at 2 days after challenge, whereas all heterozygous littermates survive the infection

immune system
• reduced formation of tartrate resistant alkaline phosphatase + (TRAP+) osteoclasts after stimulation with M-CSF/RANKL
• reduced number of TRAP+ ostoclasts in femoral bones of 18 week old mice, by 29%
• 37% reduction in osteoclast surface in the distal femoral metaphysis
• in vitro, bone marrow-derived homozygous mutant PMNs do not bind particles coated with the PMN beta3 integrin ligand peptide KGAGDVA (K,Lys; G, Gly; A, Ala; D, Asp; V, Val) and fail to generate an oxidative burst in response to surface-bound peptide
• in contrast, binding of C3bi-opsonized particles by homozygous mutant PMNs is normal
• the effector response of homozygous mutant PMNs to control stimuli phorbol dibutyrate and fMLP is also normal
• at 4 hrs after i.p. challenge with 3 x 104 virulent E. coli (018:K1:H7), homozygotes display a reduced influx of both PMNs and other cells (mainly mononuclear leukocytes) relative to heterozygous littermates
• at 24 hrs after i.p. challenge with 4.3 x 104 virulent E. coli (018:K1:H7), the % of PMNs in peritoneal lavages of homozygous mutant mice is reduced relative to that in heterozygous controls
• upon stimulation with eight-KGAGDVA-valent peptide (AGD, 20 ug/ml), bone marrow-derived homozygous mutant PMNs exhibit a significant reduction in IgG Fc receptor-mediated phagocytosis relative to wild-type or heterozygous PMNs
• higher AGD concentrations (30-40 ug/ml) not only fail to activate but actually inhibit IgG Fc receptor-mediated phagocytosis by homozygous mutant PMNs
• in vitro, purified PMNs from homozygous mutant mice display significant defects in several aspects of the antibacterial neutrophil activation process that lead to E. coli killing and effective host defense
• at 24 hrs after i.p. challenge with 4.3 x 104 virulent E. coli (018:K1:H7), >100-fold more E. coli are recovered from the peritoneal cavities and spleens of homozygous mutant mice than from heterozygote controls, suggesting a reduced ability to control infection
• at 24 hrs after E. coli challenge, all homozygotes display more signs of severe infection than control littermates, including hunched posture, ruffled fur, hypothermia, impaired ambulation, and lethargy
• following i.p. injection of 5 x 104 virulent E.coli (018:K1:H7), all 8-week-old homozygotes die at 2 days after challenge, whereas all heterozygous littermates survive the infection

hematopoietic system
• mild thrombocytopenia
• reduced formation of tartrate resistant alkaline phosphatase + (TRAP+) osteoclasts after stimulation with M-CSF/RANKL
• reduced number of TRAP+ ostoclasts in femoral bones of 18 week old mice, by 29%
• 37% reduction in osteoclast surface in the distal femoral metaphysis
• in vitro, bone marrow-derived homozygous mutant PMNs do not bind particles coated with the PMN beta3 integrin ligand peptide KGAGDVA (K,Lys; G, Gly; A, Ala; D, Asp; V, Val) and fail to generate an oxidative burst in response to surface-bound peptide
• in contrast, binding of C3bi-opsonized particles by homozygous mutant PMNs is normal
• the effector response of homozygous mutant PMNs to control stimuli phorbol dibutyrate and fMLP is also normal
• at 4 hrs after i.p. challenge with 3 x 104 virulent E. coli (018:K1:H7), homozygotes display a reduced influx of both PMNs and other cells (mainly mononuclear leukocytes) relative to heterozygous littermates
• at 24 hrs after i.p. challenge with 4.3 x 104 virulent E. coli (018:K1:H7), the % of PMNs in peritoneal lavages of homozygous mutant mice is reduced relative to that in heterozygous controls
• upon stimulation with eight-KGAGDVA-valent peptide (AGD, 20 ug/ml), bone marrow-derived homozygous mutant PMNs exhibit a significant reduction in IgG Fc receptor-mediated phagocytosis relative to wild-type or heterozygous PMNs
• higher AGD concentrations (30-40 ug/ml) not only fail to activate but actually inhibit IgG Fc receptor-mediated phagocytosis by homozygous mutant PMNs
• in vitro, purified PMNs from homozygous mutant mice display significant defects in several aspects of the antibacterial neutrophil activation process that lead to E. coli killing and effective host defense
• platelets show a considerably shorter half life when injected in wild-type recipients

skeleton
• reduced formation of tartrate resistant alkaline phosphatase + (TRAP+) osteoclasts after stimulation with M-CSF/RANKL
• reduced number of TRAP+ ostoclasts in femoral bones of 18 week old mice, by 29%
• 37% reduction in osteoclast surface in the distal femoral metaphysis

homeostasis/metabolism
• platelets show a considerably shorter half life when injected in wild-type recipients

behavior/neurological
• increased immobility times on second day of forced swimming test

cellular
• at 4 hrs after i.p. challenge with 3 x 104 virulent E. coli (018:K1:H7), homozygotes display a reduced influx of both PMNs and other cells (mainly mononuclear leukocytes) relative to heterozygous littermates
• at 24 hrs after i.p. challenge with 4.3 x 104 virulent E. coli (018:K1:H7), the % of PMNs in peritoneal lavages of homozygous mutant mice is reduced relative to that in heterozygous controls
• upon stimulation with eight-KGAGDVA-valent peptide (AGD, 20 ug/ml), bone marrow-derived homozygous mutant PMNs exhibit a significant reduction in IgG Fc receptor-mediated phagocytosis relative to wild-type or heterozygous PMNs
• higher AGD concentrations (30-40 ug/ml) not only fail to activate but actually inhibit IgG Fc receptor-mediated phagocytosis by homozygous mutant PMNs




Genotype
MGI:4939896
hm2
Allelic
Composition
Cd47tm1Fpl/Cd47tm1Fpl
Genetic
Background
C.129S7-Cd47tm1Fpl
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd47tm1Fpl mutation (4 available); any Cd47 mutation (45 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• reduced retention 3 hours after inhibitory avoidance training

nervous system
• significantly reduced slope of population excitatory postsynaptic potential upon tetanic stimulation
• population spike amplitudes are lower

hematopoietic system
• mild thrombocytopenia
• reduced formation of tartrate resistant alkaline phosphatase + (TRAP+) osteoclasts after stimulation with M-CSF/RANKL
• reduced number of TRAP+ ostoclasts in femoral bones of 18 week old mice, by 29%
• 37% reduction in osteoclast surface in the distal femoral metaphysis
• platelets show a considerably shorter half life when injected in wild-type recipients

skeleton
• reduced formation of tartrate resistant alkaline phosphatase + (TRAP+) osteoclasts after stimulation with M-CSF/RANKL
• reduced number of TRAP+ ostoclasts in femoral bones of 18 week old mice, by 29%
• 37% reduction in osteoclast surface in the distal femoral metaphysis

vision/eye
N
• electroretinograms are normal

homeostasis/metabolism
• platelets show a considerably shorter half life when injected in wild-type recipients

immune system
• reduced formation of tartrate resistant alkaline phosphatase + (TRAP+) osteoclasts after stimulation with M-CSF/RANKL
• reduced number of TRAP+ ostoclasts in femoral bones of 18 week old mice, by 29%
• 37% reduction in osteoclast surface in the distal femoral metaphysis




Genotype
MGI:2180896
hm3
Allelic
Composition
Cd47tm1Fpl/Cd47tm1Fpl
Genetic
Background
involves: 129S7/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd47tm1Fpl mutation (4 available); any Cd47 mutation (45 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• homozygotes display a reduction in the CD3+ fraction of peripheral lymphocytes relative to control littermates
• however, no significant differences in platelet, PMN or WBC count are observed relative to wild-type or heterozygous controls at all ages tested
• neutrophil infiltration into ischemic regions is considerably reduced

nervous system
• fewer hippocampal neurons with an enlarged growth cone at the end of the primary axon
• hippocampal neurons in culture develop fewer dendrites than do controls after 3-7 days
• reduced branching of dendrites at 3-7 but not at 14-21 days
• total length of dendrites is markedly reduced at 3 and 7 days in culture
• ischemic swelling after occlusion/reperfusion in the brain is similar to controls at 24 hours but does not undergo further development as it does in controls
• infarct volume, corrected for hemispheric swelling is considerably smaller than in controls at both 24 and 72 hours
• neutrophil infiltration into ischemic regions is considerably reduced

integument
N
• normal cutaneous architecture is maintained in myocutaneous skin flap preparations
• improved myocutaneous skin flap survival 7 days after the surgery as compared to controls
• reduced necrosis

limbs/digits/tail
• better tissue survival after proximal ligation of the external iliac and common femoral
• minimal or no clinical evidence of tissue necrosis
• increased vascular remodeling and vascular perfusion by 1 week after the operation

cardiovascular system
• increased vascular remodeling and vascular perfusion by proximal ligation of the external iliac and common femoral

cellular
• mitochondrial function is maintained better 1 week after proximal ligation of the external iliac and common femoral artery than in controls

immune system
• homozygotes display a reduction in the CD3+ fraction of peripheral lymphocytes relative to control littermates
• however, no significant differences in platelet, PMN or WBC count are observed relative to wild-type or heterozygous controls at all ages tested
• neutrophil infiltration into ischemic regions is considerably reduced




Genotype
MGI:4939899
hm4
Allelic
Composition
Cd47tm1Fpl/Cd47tm1Fpl
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd47tm1Fpl mutation (4 available); any Cd47 mutation (45 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
respiratory system
• accumulation of excess fluid in the lungs 24 hours after intratracheal instillation with LPS or after lung infection with E. coli is reduced
• bronchoalveolar lavage protein concentrations reduced

hematopoietic system
• macrophage differentiation into osteoclasts is severely reduced in culture
• increased doses of RANKL increases osteoclast formation
• relative to controls after intratracheal instillation with LPS or after lung infection with E. coli
• relative to controls after intratracheal instillation with LPS or after lung infection with E. coli
• significantly reduced relative to controls in both blood and bronchoalveolar lavage after intratracheal instillation with LPS
• significantly reduced relative to controls in both blood and bronchoalveolar lavage after intratracheal instillation with LPS or after lung infection with E. coli

skeleton
• macrophage differentiation into osteoclasts is severely reduced in culture
• increased doses of RANKL increases osteoclast formation
• by microCT analysis
• thickness but not number is increased in tibias
• reduced cleavage of type I collagen
• osteoclast bone resorption is reduced unless RANKL concentration is elevated

cardiovascular system
• in active light cycle
• increased 15% relative to controls under isofluorane anaesthesia
• in active light cycle
• peripheral diastolic pressure is significantly increased
• peripheral systolic blood pressure is significantly increased

integument
• hair is preserved after 25 Gy irradiation
• minimal or no skin ulceration 8 weeks after irradiation
• hair follicles and skin architecture are better preserved than in controls

muscle
N
• no leg muscle atrophy after irradiation
• limb flexibility maintained
• less loss of muscle fibers and nuclei after irradiation

homeostasis/metabolism
• accumulation of excess fluid in the lungs 24 hours after intratracheal instillation with LPS or after lung infection with E. coli is reduced
• bronchoalveolar lavage protein concentrations reduced
• MIP-2 levels in bronchoalveolar fluid are reduced 4 hours after LPS challenge but not after 24 hours
• levels in bronchoalveolar fluid are reduced 4 hours after LPS challenge but not after 24 hours

immune system
• macrophage differentiation into osteoclasts is severely reduced in culture
• increased doses of RANKL increases osteoclast formation
• significantly reduced relative to controls in both blood and bronchoalveolar lavage after intratracheal instillation with LPS
• significantly reduced relative to controls in both blood and bronchoalveolar lavage after intratracheal instillation with LPS or after lung infection with E. coli
• MIP-2 levels in bronchoalveolar fluid are reduced 4 hours after LPS challenge but not after 24 hours
• levels in bronchoalveolar fluid are reduced 4 hours after LPS challenge but not after 24 hours
• enhanced survival 72 hours after E. coli infection with 5 x 10 6 CFU
• after E coli infection of the lungs, bacterial levels remain high in the lungs but are reduced in the blood

neoplasm
• fewer tumors develop in femur, tibia and mandible from B16-F10 melanoma cell injection

mortality/aging
• enhanced survival 72 hours after E. coli infection with 5 x 10 6 CFU

cellular
• macrophage differentiation into osteoclasts is severely reduced in culture
• increased doses of RANKL increases osteoclast formation

nervous system
N
• exhibit normal neurite differentiation




Genotype
MGI:4939898
hm5
Allelic
Composition
Cd47tm1Fpl/Cd47tm1Fpl
Genetic
Background
NOD.129S7-Cd47tm1Fpl
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd47tm1Fpl mutation (4 available); any Cd47 mutation (45 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• death between 300 and 550 days from severe hemolytic anemia

hematopoietic system
• expanded erythroid cell numbers in vertebrae, sternum, rib tips and long bone marrow cavities
• severe and rapidly fatal hemolytic anemia develops between 180 and 280 days of age whereas NOD controls develop only a mildly hemolytic anemia at 300-550 days
• anemia is secondary to rapid destruction of RBC
• high levels of IgG and IgM on RBC of anemic mice
• expanded erythroid cell numbers in long bone marrow cavities
• hematocrit at 194 days is 33% of controls
• at 194 days
• massively enlarged spleen at death, 10X normal size
• majority of spleen cels are erythropoietic

immune system
• massively enlarged spleen at death, 10X normal size
• majority of spleen cels are erythropoietic

growth/size/body
• massively enlarged spleen at death, 10X normal size




Genotype
MGI:2180897
ht6
Allelic
Composition
Cd47tm1Fpl/Cd47+
Genetic
Background
B6.129S7-Cd47tm1Fpl
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd47tm1Fpl mutation (4 available); any Cd47 mutation (45 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• whereas all 8-week-old heterozygotes survive after i.p. injection of 5 x 104 virulent E.coli (018:K1:H7), some heterozygotes succumb to infection when a 10-fold higher inoculum is used

immune system
• whereas all 8-week-old heterozygotes survive after i.p. injection of 5 x 104 virulent E.coli (018:K1:H7), some heterozygotes succumb to infection when a 10-fold higher inoculum is used




Genotype
MGI:5538575
cx7
Allelic
Composition
Rag2tm1Fwa/Rag2tm1Fwa
Cd47tm1Fpl/Cd47tm1Fpl
Il2rgtm1Cgn/Y
Genetic
Background
involves: 129P2/OlaHsd * 129S/SvEv * 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd47tm1Fpl mutation (4 available); any Cd47 mutation (45 available)
Il2rgtm1Cgn mutation (4 available); any Il2rg mutation (168 available)
Rag2tm1Fwa mutation (48 available); any Rag2 mutation (117 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• HIV-infected BLT transplanted mice exhibit a loss of CD4+ T cells and an increase in CD8+ T cells
• a high proportion of CD38+ CD8+ T cells appear activated in HIV-infected BLT transplanted mice
• spleen and lymph nodes lack lymphocytes
• HIV-infected BLT transplanted mice exhibit a loss of CD4+ T cells and an increase in CD8+ T cells
• mice fail to develop peripheral lymph nodes
• 54% of BLT transplanted mice inoculated intrarectally with HIV become infected with plasma viral titers peaking between 2 and 4 weeks
• 100% of transplanted mice inoculated intraperitoneally with HIV become infected
• HIV-infected BLT transplanted mice exhibit a loss of CD4+ T cells and an increase in CD8+ T cells
• a high proportion of CD8+ T cells appear activated in HIV-infected BLT transplanted mice
• infected mice produce HIV-specific antibodies and can mount HIV-specific T cell responses
• mice are tolerized to xenotransplantation with human bone marrow, liver, thymus (BLT)
• mice average 1x106 human leukocytes/mL blood 12 weeks after transplantation and levels remain stable or improve through 21 weeks
• >80% of leukocytes in peripheral circulation are human
• transplanted mice have higher levels of multipotent bone marrow/hematopoietic stem cells than mice heterozygous for the Cd47tm1Fpl allele
• GVHD is not evident in mice 25 weeks post-transplantation
• human thymic organoids are highly vascularized
• large and small intestines of transplanted mice contain CD4+ and CD8+ human T cells

hematopoietic system
• HIV-infected BLT transplanted mice exhibit a loss of CD4+ T cells and an increase in CD8+ T cells
• a high proportion of CD38+ CD8+ T cells appear activated in HIV-infected BLT transplanted mice
• spleen and lymph nodes lack lymphocytes
• HIV-infected BLT transplanted mice exhibit a loss of CD4+ T cells and an increase in CD8+ T cells





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory